Abstract
Background: Tobacco smoking has detrimental influence on human health and is one of the leading causes of preventable mortality worldwide, associated with lung cancer, chronic obstructive lung disease and cardiovascular disease.
Aim: The analysis of the influence of tobacco smoking on pathology of the anterior segment of the eye in adults and children. Methods: A comprehensive review of the literature performed through MEDLINE and PubMed searches, was published during the period 2000-2016. Results: In adults, tobacco smoking is associated with hyperopia, delayed corneal epithelial healing and progression of Fuchs’ endothelial corneal dystrophy. Smoking is a strong risk factor for age-related nuclear cataract. However, smoking is not associated with pterygium, and its influence on dry eye symptoms, central corneal thickness and progression of primary open glaucoma remains controversial. Smoking during pregnancy increases risk of convergent or divergent strabismus or poor stereo acuity, however, its influence on anophtalmia, microphtalmia, amblyopia and hyperopic refractive error is controversial. Conclusion: Tobacco smoking plays an important role in the pathogenesis of many diseases of anterior eye segment leading to visual impairment in adults and children.Keywords: Tobacco smoking, refraction, cornea, cataract, glaucoma, adults, children.
Current Pharmaceutical Design
Title:Smoking and Eye Pathologies. A Systemic Review. Part I. Anterior Eye Segment Pathologies
Volume: 23 Issue: 4
Author(s): Malgorzata Nita and Andrzej Grzybowski
Affiliation:
Keywords: Tobacco smoking, refraction, cornea, cataract, glaucoma, adults, children.
Abstract: Background: Tobacco smoking has detrimental influence on human health and is one of the leading causes of preventable mortality worldwide, associated with lung cancer, chronic obstructive lung disease and cardiovascular disease.
Aim: The analysis of the influence of tobacco smoking on pathology of the anterior segment of the eye in adults and children. Methods: A comprehensive review of the literature performed through MEDLINE and PubMed searches, was published during the period 2000-2016. Results: In adults, tobacco smoking is associated with hyperopia, delayed corneal epithelial healing and progression of Fuchs’ endothelial corneal dystrophy. Smoking is a strong risk factor for age-related nuclear cataract. However, smoking is not associated with pterygium, and its influence on dry eye symptoms, central corneal thickness and progression of primary open glaucoma remains controversial. Smoking during pregnancy increases risk of convergent or divergent strabismus or poor stereo acuity, however, its influence on anophtalmia, microphtalmia, amblyopia and hyperopic refractive error is controversial. Conclusion: Tobacco smoking plays an important role in the pathogenesis of many diseases of anterior eye segment leading to visual impairment in adults and children.Export Options
About this article
Cite this article as:
Nita Malgorzata and Grzybowski Andrzej, Smoking and Eye Pathologies. A Systemic Review. Part I. Anterior Eye Segment Pathologies, Current Pharmaceutical Design 2017; 23 (4) . https://dx.doi.org/10.2174/1381612822666161129152041
DOI https://dx.doi.org/10.2174/1381612822666161129152041 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment
Current Pharmaceutical Design The Newborn Individualized Developmental Care and Assessment Program (NIDCAP) with Kangaroo Mother Care (KMC): Comprehensive Care for Preterm Infants
Current Women`s Health Reviews Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Depot Based Drug Delivery System for the Management of Depression
Current Drug Delivery Choroidal Thickness Measured by Ocular Coherence Tomography (SD-OCT) and Body Mass Index in Healthy Saudi Women: A Cross-sectional Controlled Study
Current Medical Imaging The Contrast Sensitivity Test in Early Detection of Ocular Changes in the Relation to the Type I Diabetes Mellitus Compensation in Children,Teenagers, and Young Adults
Recent Patents on Inflammation & Allergy Drug Discovery Signaling with Homeoprotein Transcription Factors in Development and Throughout Adulthood
Current Genomics Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors
Combinatorial Chemistry & High Throughput Screening A Review of Current and Prospective Treatments for Channelopathies, with a Focus on Gene and Protein Therapy
Current Pharmaceutical Design Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Synaptic Elimination in Neurological Disorders
Current Neuropharmacology The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?
Reviews on Recent Clinical Trials Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation Genetic Basis of Mitochondrial Optic Neuropathies
Current Molecular Medicine Review of Pediatric Uveitis
Current Pediatric Reviews Insights in Specific Cerebellar and Cerebral Activations in Blind Subjects
Current Medical Imaging Giant Cell Arteritis – A Series of Cases and Review of Literature
Current Rheumatology Reviews Non-Antidepressant Treatment of Generalized Anxiety Disorder
Current Clinical Pharmacology The Fall in Older Adults: Physical and Cognitive Problems
Current Aging Science State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology